181 related articles for article (PubMed ID: 34999565)
1. Timing of selective basal ganglia white matter loss in premanifest Huntington's disease.
Zeun P; McColgan P; Dhollander T; Gregory S; Johnson EB; Papoutsi M; Nair A; Scahill RI; Rees G; Tabrizi SJ;
Neuroimage Clin; 2022; 33():102927. PubMed ID: 34999565
[TBL] [Abstract][Full Text] [Related]
2. Intact sensory-motor network structure and function in far from onset premanifest Huntington's disease.
Gorges M; Müller HP; Mayer IM; Grupe GS; Kammer T; Grön G; Kassubek J; Landwehrmeyer GB; Wolf RC; Orth M
Sci Rep; 2017 Mar; 7():43841. PubMed ID: 28266655
[TBL] [Abstract][Full Text] [Related]
3. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
[TBL] [Abstract][Full Text] [Related]
4. Microstructural brain abnormalities in Huntington's disease: A two-year follow-up.
Odish OF; Leemans A; Reijntjes RH; van den Bogaard SJ; Dumas EM; Wolterbeek R; Tax CM; Kuijf HJ; Vincken KL; van der Grond J; Roos RA
Hum Brain Mapp; 2015 Jun; 36(6):2061-74. PubMed ID: 25644819
[TBL] [Abstract][Full Text] [Related]
5. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
Scahill RI; Zeun P; Osborne-Crowley K; Johnson EB; Gregory S; Parker C; Lowe J; Nair A; O'Callaghan C; Langley C; Papoutsi M; McColgan P; Estevez-Fraga C; Fayer K; Wellington H; Rodrigues FB; Byrne LM; Heselgrave A; Hyare H; Sampaio C; Zetterberg H; Zhang H; Wild EJ; Rees G; Robbins TW; Sahakian BJ; Langbehn D; Tabrizi SJ
Lancet Neurol; 2020 Jun; 19(6):502-512. PubMed ID: 32470422
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington's disease.
Gargouri F; Messé A; Perlbarg V; Valabregue R; McColgan P; Yahia-Cherif L; Fernandez-Vidal S; Ben Hamida A; Benali H; Tabrizi S; Durr A; Lehéricy S
Hum Brain Mapp; 2016 Nov; 37(11):4112-4128. PubMed ID: 27400836
[TBL] [Abstract][Full Text] [Related]
7. Investigating longitudinal changes to frontal cortico-striatal tracts in Huntington's disease: the IMAGE-HD study.
Tan B; Shishegar R; Oldham S; Fornito A; Poudel G; Georgiou-Karistianis N
Brain Imaging Behav; 2022 Dec; 16(6):2457-2466. PubMed ID: 35768755
[TBL] [Abstract][Full Text] [Related]
8. White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease.
De Paepe AE; Sierpowska J; Garcia-Gorro C; Martinez-Horta S; Perez-Perez J; Kulisevsky J; Rodriguez-Dechicha N; Vaquer I; Subira S; Calopa M; Muñoz E; Santacruz P; Ruiz-Idiago J; Mareca C; de Diego-Balaguer R; Camara E
Neuroimage Clin; 2019; 24():101965. PubMed ID: 31401404
[TBL] [Abstract][Full Text] [Related]
9. Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease.
Orth M; Gregory S; Scahill RI; Mayer IS; Minkova L; Klöppel S; Seunarine KK; Boyd L; Borowsky B; Reilmann R; Bernhard Landwehrmeyer G; Leavitt BR; Roos RA; Durr A; Rees G; Rothwell JC; Langbehn D; Tabrizi SJ;
Hum Brain Mapp; 2016 Dec; 37(12):4615-4628. PubMed ID: 27477323
[TBL] [Abstract][Full Text] [Related]
10. Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.
Hong Y; O'Donnell LJ; Savadjiev P; Zhang F; Wassermann D; Pasternak O; Johnson H; Paulsen J; Vonsattel JP; Makris N; Westin CF; Rathi Y
Hum Brain Mapp; 2018 Oct; 39(10):3871-3883. PubMed ID: 29797744
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
Poudel GR; Stout JC; Domínguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
[TBL] [Abstract][Full Text] [Related]
12. Motor network structure and function are associated with motor performance in Huntington's disease.
Müller HP; Gorges M; Grön G; Kassubek J; Landwehrmeyer GB; Süßmuth SD; Wolf RC; Orth M
J Neurol; 2016 Mar; 263(3):539-49. PubMed ID: 26762394
[TBL] [Abstract][Full Text] [Related]
13. Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study.
Johnson EB; Parker CS; Scahill RI; Gregory S; Papoutsi M; Zeun P; Osborne-Crowley K; Lowe J; Nair A; Estevez-Fraga C; Fayer K; Rees G; Zhang H; Tabrizi SJ;
EBioMedicine; 2021 Mar; 65():103266. PubMed ID: 33706250
[TBL] [Abstract][Full Text] [Related]
14. White matter connectivity reflects clinical and cognitive status in Huntington's disease.
Poudel GR; Stout JC; Domínguez D JF; Salmon L; Churchyard A; Chua P; Georgiou-Karistianis N; Egan GF
Neurobiol Dis; 2014 May; 65():180-7. PubMed ID: 24480090
[TBL] [Abstract][Full Text] [Related]
15. In vivo characterization of white matter pathology in premanifest huntington's disease.
Zhang J; Gregory S; Scahill RI; Durr A; Thomas DL; Lehericy S; Rees G; Tabrizi SJ; Zhang H;
Ann Neurol; 2018 Oct; 84(4):497-504. PubMed ID: 30063250
[TBL] [Abstract][Full Text] [Related]
16. Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes.
McColgan P; Gregory S; Seunarine KK; Razi A; Papoutsi M; Johnson E; Durr A; Roos RAC; Leavitt BR; Holmans P; Scahill RI; Clark CA; Rees G; Tabrizi SJ;
Biol Psychiatry; 2018 Mar; 83(5):456-465. PubMed ID: 29174593
[TBL] [Abstract][Full Text] [Related]
17. Voluntary saccade inhibition deficits correlate with extended white-matter cortico-basal atrophy in Huntington's disease.
Vaca-Palomares I; Coe BC; Brien DC; Campos-Romo A; Munoz DP; Fernandez-Ruiz J
Neuroimage Clin; 2017; 15():502-512. PubMed ID: 28649493
[TBL] [Abstract][Full Text] [Related]
18. Progressive alterations in white matter microstructure across the timecourse of Huntington's disease.
Estevez-Fraga C; Elmalem MS; Papoutsi M; Durr A; Rees EM; Hobbs NZ; Roos RAC; Landwehrmeyer B; Leavitt BR; Langbehn DR; Scahill RI; Rees G; Tabrizi SJ; Gregory S
Brain Behav; 2023 Apr; 13(4):e2940. PubMed ID: 36917716
[TBL] [Abstract][Full Text] [Related]
19. Early grey matter changes in structural covariance networks in Huntington's disease.
Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal diffusion changes in prodromal and early HD: Evidence of white-matter tract deterioration.
Shaffer JJ; Ghayoor A; Long JD; Kim RE; Lourens S; O'Donnell LJ; Westin CF; Rathi Y; Magnotta V; Paulsen JS; Johnson HJ
Hum Brain Mapp; 2017 Mar; 38(3):1460-1477. PubMed ID: 28045213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
